Details for Patent: 9,296,782

✉ Email this page to a colleague

Which drugs does patent 9,296,782 protect, and when does it expire?

Patent 9,296,782 protects VOSEVI and is included in one NDA.

This patent has eighty-seven patent family members in forty-one countries.

Summary for Patent: 9,296,782

Title:	Inhibitors of hepatitis C virus
Abstract:	Compounds of Formula I are disclosed ##STR00001## As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.
Inventor(s):	Bjornson; Kyla (San Lorenzo, CA), Canales; Eda (San Mateo, CA), Cottell; Jeromy J. (Redwood City, CA), Karki; Kapil Kumar (Foster City, CA), Katana; Ashley Anne (San Mateo, CA), Kato; Darryl (San Francisco, CA), Kobayashi; Tetsuya (Sunnyvale, CA), Link; John O. (San Francisco, CA), Martinez; Ruben (South San Francisco, CA), Phillips; Barton W. (San Mateo, CA), Pyun; Hyung-Jung (Fremont, CA), Sangi; Michael (Oakland, CA), Schrier; Adam James (Redwood City, CA), Siegel; Dustin (Foster City, CA), Taylor; James G. (San Mateo, CA), Tran; Chinh Viet (San Diego, CA), Trejo Martin; Teresa Alejandra (Union City, CA), Vivian; Randall W. (San Mateo, CA), Yang; Zheng-Yu (Palo Alto, CA), Zablocki; Jeff (Los Altos, CA), Zipfel; Sheila (San Mateo, CA)
Assignee:	Gilead Sciences, Inc. (Foster City, CA)
Application Number:	13/934,090
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 9,296,782

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Gilead Sciences Inc	VOSEVI	sofosbuvir; velpatasvir; voxilaprevir	TABLET;ORAL	209195-001	Jul 18, 2017		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,296,782

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	3903	⤷ Sign Up
Argentina	091661	⤷ Sign Up
Australia	2013286729	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.